Russell Investments Group
MYGN icon

Russell Investments Group’s Myriad Genetics MYGN Stock Holding History

Russell Investments Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
206,450
+35,098
+20% +$159K ﹤0.01% 2381
2026
Q1 		$769K Buy
171,352
+4,292
+3% +$22.4K ﹤0.01% 2335
2025
Q4 		$1.03M Sell
167,060
-6,122
-4% -$44.4K ﹤0.01% 2213
2025
Q3 		$1.25M Buy
173,182
+90,804
+110% +$539K ﹤0.01% 2103
2025
Q2 		$437K Buy
+82,378
New +$487K ﹤0.01% 2385
2024
Q4 		– Sell
-3,954
Closed -$108K – 3760
2024
Q3 		$108K Buy
3,954
+581
+17% +$15.7K ﹤0.01% 2643
2024
Q2 		$82.5K Buy
3,373
+3,342
+10,781% +$73.3K ﹤0.01% 2666
2024
Q1 		$661 Hold
31
– – ﹤0.01% 3168
2023
Q4 		$593 Buy
+31
New +$536 ﹤0.01% 3110
2023
Q3 		– Sell
-668
Closed -$15.5K – 3587
2023
Q2 		$15.5K Hold
668
– – ﹤0.01% 2888
2023
Q1 		$15.5K Sell
668
-41,162
-98% -$836K ﹤0.01% 2841
2022
Q4 		$607K Hold
41,830
– – ﹤0.01% 2205
2022
Q3 		$797K Sell
41,830
-252
-0.6% -$5.78K ﹤0.01% 2034
2022
Q2 		$763K Hold
42,082
– – ﹤0.01% 2081
2022
Q1 		$1.06M Sell
42,082
-26,380
-39% -$675K ﹤0.01% 1929
2021
Q4 		$1.89M Buy
68,462
+22,044
+47% +$639K ﹤0.01% 1834
2021
Q3 		$1.5M Sell
46,418
-17,745
-28% -$589K ﹤0.01% 1995
2021
Q2 		$1.96M Sell
64,163
-57,100
-47% -$1.65M ﹤0.01% 1935
2021
Q1 		$3.69M Sell
121,263
-29,952
-20% -$850K 0.01% 1523
2020
Q4 		$2.99M Sell
151,215
-164,389
-52% -$2.65M 0.01% 1538
2020
Q3 		$4.11M Buy
315,604
+102,206
+48% +$1.29M 0.01% 1249
2020
Q2 		$2.41M Buy
213,398
+1,751
+0.8% +$24.9K 0.01% 1518
2020
Q1 		$3.05M Sell
211,647
-62,684
-23% -$1.32M 0.01% 1239
2019
Q4 		$7.34M Sell
274,331
-81,466
-23% -$2.24M 0.01% 999
2019
Q3 		$10.2M Sell
355,797
-47,769
-12% -$1.39M 0.02% 846
2019
Q2 		$10.9M Sell
403,566
-56,499
-12% -$1.6M 0.02% 836
2019
Q1 		$15.9M Sell
460,065
-191,524
-29% -$5.83M 0.03% 668
2018
Q4 		$18.7M Buy
651,589
+39,023
+6% +$1.4M 0.04% 533
2018
Q3 		$28.3M Sell
612,566
-10,305
-2% -$458K 0.05% 415
2018
Q2 		$23.2M Sell
622,871
-448,225
-42% -$15.1M 0.05% 472
2018
Q1 		$31.7M Buy
1,071,096
+4,865
+0.5% +$165K 0.05% 399
2017
Q4 		$36.9M Sell
1,066,231
-85,684
-7% -$2.89M 0.06% 370
2017
Q3 		$41.7M Buy
1,151,915
+78,798
+7% +$2.25M 0.07% 341
2017
Q2 		$27.7M Sell
1,073,117
-42,716
-4% -$907K 0.05% 470
2017
Q1 		$21.4M Buy
1,115,833
+7,113
+0.6% +$126K 0.04% 546
2016
Q4 		$18.6M Buy
+1,108,720
New +$20.1M 0.04% 578

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Russell Investments Group's MYGN Position: Q2 2026 in Review

Russell Investments Group increased its Myriad Genetics (MYGN) stake by 20% in Q2 2026, buying an estimated $159K and bringing the position to 206,450 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Russell Investments Group first reported a position in MYGN in Q4 2016 and has held it in 36 quarters since. The position peaked at $41.7M in Q3 2017. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Russell Investments Group held 206,450 shares of Myriad Genetics worth $1.18M as of Q2 2026.
  • Russell Investments Group bought 35,098 Myriad Genetics shares in Q2 2026, an estimated $159K.
  • Myriad Genetics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2381 holding.
  • Russell Investments Group first reported a position in Myriad Genetics in Q4 2016 and has held it in 36 quarters since.
  • Russell Investments Group's Myriad Genetics position peaked at $41.7M in Q3 2017.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.